Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality
FRONTIERS IN CARDIOVASCULAR MEDICINE(2022)
关键词
cardiovascular, renal, death, type 2 diabetes, SGLT 2 inhibitors, GLP-1RAs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
FRONTIERS IN CARDIOVASCULAR MEDICINE(2022)